Bilibili Inc.: Form 20-F/A for the period ended Dec 31, 2018
Filed with the SEC on Apr 12, 2019 and accepted by EDGAR at Apr 12, 2019, 16:28 ET.
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2018-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2018-01-01 to 2018-12-31 | $600.5m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 12 months2018-01-01 to 2018-12-31 | $476.1m | us-gaap:CostOfRevenue |
| Gross profit | 12 months2018-01-01 to 2018-12-31 | $124.4m | us-gaap:GrossProfit |
| Research and development | 12 months2018-01-01 to 2018-12-31 | $78.2m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 12 months2018-01-01 to 2018-12-31 | −$106.0m | us-gaap:OperatingIncomeLoss |
| Income tax | 12 months2018-01-01 to 2018-12-31 | $3.8m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months2018-01-01 to 2018-12-31 | −$82.2m | us-gaap:ProfitLoss |
| Diluted EPS | 12 months2018-01-01 to 2018-12-31 | −$0.38 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months2018-01-01 to 2018-12-31 | −$0.38 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2018-01-01 to 2018-12-31 | 233,047,703 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2018-01-01 to 2018-12-31 | $107.2m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2018-01-01 to 2018-12-31 | $42.7m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2018-12-31 | $514.9m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2018-12-31 | $952.7m | us-gaap:AssetsCurrent |
| Total assets | At period end2018-12-31 | $1.53bn | us-gaap:Assets |
| Current liabilities | At period end2018-12-31 | $479.8m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2018-12-31 | $479.8m | us-gaap:Liabilities |
| Shareholders' equity | At period end2018-12-31 | $1.01bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001104659-19-021128. Last ingested by Listed: Nov 3, 2026, 18:50 ET. Listed shows no prices and gives no investment advice.